Track topics on Twitter Track topics that are important to you
THURSDAY, Aug. 15, 2019 -- Nonpersistence and low adherence are common among younger adults initiating antihypertensive medications and have not improved over time, according to a study published in the July issue of Hypertension. Gabriel S. Tajeu,...
Original Article: Nonpersistence, Low Adherence to BP Meds Common in Under 65sNEXT ARTICLE
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...